To verify the sensitivity of HER2-overexpressing breast cancer cell lines to HIF-2α-specific inhibition, we tested the effect of HIF-2α-specific translation inhibitor C76 [56] on the growth rates of eight breast cancer cell lines, including three ER-positive/HER2-negative lines (MCF7, T47D, ZR751), three naturally HER2-positive cell lines (BT474, MDA-MB-361, SKBR3) and two triple negative cell lines (HBL100, MDA-MB-231) (Fig. 7d). Here, EPAS1 is linked to breast carcinoma.